FDA Inspection 1296460 — OneLegacy
The FDA completed an inspection of OneLegacy on December 15, 2025 in Irwindale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 15, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Irwindale, CA (United States)